Get the tools used by (smart)2 investors.

P/E Ratio (Adjusted) for Merck & Company Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

MRK: Merck & Company Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, incl...

89.23 USD
Price
USD
Fair Value
Upside
81.04 - 134.63
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Merck & Company Inc's P/E Ratio (Adjusted):

Dec 2016Dec 2018Dec 2020Dec 2022Dec 202410.0x20.0x30.0x40.0x50.0x

Performance Summary
  • Merck's latest twelve months p/e ratio (adjusted) is 10.9x
  • Merck's p/e ratio (adjusted) for fiscal years ending December 2020 to 2024 averaged 17.1x.
  • Merck's operated at median p/e ratio (adjusted) of 17.5x from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Merck's p/e ratio (adjusted) peaked in December 2020 at 20.7x.
  • Merck's p/e ratio (adjusted) hit its 5-year low in December 2024 of 10.9x.
  • Merck's p/e ratio (adjusted) decreased in 2021 (20.1x, -2.9%), 2022 (16.2x, -19.5%), and 2024 (10.9x, -37.7%) and increased in 2020 (20.7x, +6.3%) and 2023 (17.5x, +8.1%).

How does Merck&Co's P/E Ratio (Adjusted) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Merck & Company Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: P/E Ratio (Adjusted)

Hide this widget
pe_ltm_adj
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to P/E Ratio (Adjusted) in the valuation category include:

  • 3 Year Price Total Return - The total change in price (adjusted of dividends and splits when applicable) over the last 3 years.
  • Avg EV / EBITDA (10y) - Ten-year quarterly average EV / EBITDA.
  • Shares Outstanding CAGR (5y) - Five-year compound annual growth rate in shares outstanding.
  • Price / NNWC - Compares the current stock price to the Net Net Working Capital (NNWC) where NNWC equals Cash & Equivalents + (Accounts Receivables x 0.75) + (Inventory x 0.5) - Total Liabilities.
View Full List

Search for metric or datapoint

P/E Ratio (Adjusted)

Indicates the multiple of earnings, adjusted for usual items, that stock investors are willing to pay for one share of the firm.

Definition of P/E Ratio (Adjusted)

Hide this widget

No data available

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-94.1x-44.1x5.9x86.9x0400800

The chart above depicts the distribution of p/e ratio (adjusted) for companies operating in the Healthcare sector in the Developed economic region. Over 2,455 companies were considered in this analysis, and 2,362 had meaningful values. The average p/e ratio (adjusted) of companies in the sector is 0.5x with a standard deviation of 19.0x.

Merck & Company Inc's P/E Ratio (Adjusted) of 10.9x ranks in the 80.1% percentile for the sector. The following table provides additional summary stats:

P/E Ratio (Adjusted) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,460
Included Constituents2,362
Min-93.7x
Max86.6x
Median-1.3x
Mean0.5x
Standard Deviation19.0x

You can find companies with similar p/e ratio (adjusted) using this stock screener.

All rights reserved. Terms Of Use